Comparing nab-paclitaxel and solvent-based paclitaxel in platinum-resistant ovarian cancer: evidence and perspectives
Despite the absence of direct trials, experts considered evidence sufficient to support nab-paclitaxel as a viable alternative to sb-paclitaxel in platinum-resistant ovarian cancer with comparable efficacy, safety, and fewer hypersensitivity reactions. Additional randomized trials were not deemed necessary.
Authors
- Jalid Sehouli (ORCID: https://orcid.org/0000-0002-5963-6623)
- Jolijn Boer (ORCID: https://orcid.org/0009-0009-0873-4686)
- Christina Fotopoulou (ORCID: https://orcid.org/0000-0001-6375-9645)
- Alexander Krannich (ORCID: https://orcid.org/0000-0002-4025-6495)
- Robert Louis Coleman (ORCID: https://orcid.org/0000-0001-9343-8754)
- Meghan R. Forrest (ORCID: https://orcid.org/0000-0002-9879-1925)
- Giorgio Bogani (ORCID: https://orcid.org/0000-0001-8373-8569)
- Matthias Rose (ORCID: https://orcid.org/0000-0001-5233-3139)
- Chisato Ito (ORCID: https://orcid.org/0000-0002-8349-8224)
- Tobias Kurth (ORCID: https://orcid.org/0000-0001-7169-2620)
- Franziska Sinn
- Pauline Wimberger (ORCID: https://orcid.org/0000-0002-7380-577X)
- Elena Fischer (ORCID: https://orcid.org/0009-0001-6891-7988)
- Jacek Grabowski (ORCID: https://orcid.org/0000-0001-6204-017X)
- Susanne Fechner
- Gülten Oskay-Öczelik
- Andrea Krull
- Bradley Monk (ORCID: https://orcid.org/0000-0002-0680-3184)
- Thomas Ecker
- Ainhoa Madariaga (ORCID: https://orcid.org/0000-0001-7166-9762)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Hammersmith Hospital (GB)
- Research Institute Hospital 12 de Octubre (ES)
- German Cancer Society (DE)
- Asklepios Fachklinikum Tiefenbrunn (DE)
- Florida Cancer Specialists & Research Institute (US)
- Cancer Clinic (US)
- Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- University Hospital Carl Gustav Carus (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- International Journal of Gynecological Cancer
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.ijgc.2025.102841
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00